TAK Overview
Upcoming Projects (TAK)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (TAK)
-
Discussing Hypoparathyroidism with a Physician Who Has Prescribed Natpara
Tickers: ASND, TAK
Executed On: Mar 20, 2019 at 10:00 AM EDT -
A Second Opinion: Discussing the recent mixed results from Aurinia' Phase 2 trial in dry-eye for VOS vs. Restasis
Tickers: AUPH, AGN, TAK
Executed On: Mar 04, 2019 at 02:00 PM EST -
Discussing the recent mixed results from Aurinia' Phase 2 trial in dry-eye for VOS vs. Restasis
Tickers: AUPH, AGN, TAK
Executed On: Feb 15, 2019 at 01:30 PM EST
Upcoming & Overdue Catalysts (TAK)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (TAK)
-
Takeda Pharmaceutical Co(TAK) to sell eye drug Xiidra to Novartis AG(NVS)
Tickers: NVS, TAK
Announcement Date: May 08, 2019
